Simplify Asset Management’s Jasper Therapeutics JSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-20,302
Closed -$1.45M – 152
2025
Q3
$1.45M Buy
+20,302
New +$1.85M 0.03% 67
2025
Q1
– Sell
-667
Closed -$428K – 100
2024
Q4
$428K Buy
+667
New +$417K 0.02% 80

Other funds holding JSPR

Simplify Asset Management's JSPR Position: Q4 2025 in Review

Simplify Asset Management sold out of Jasper Therapeutics (JSPR) in Q4 2025, closing a stake of 20,302 shares — an estimated $1.45M sold.

Simplify Asset Management first reported a position in JSPR in Q4 2024 and held it in 2 quarters. The position peaked at $1.45M in Q3 2025. 53 funds tracked by Wall St. Rank hold JSPR as of Q4 2025.

  • Simplify Asset Management reported no remaining Jasper Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Simplify Asset Management sold 20,302 Jasper Therapeutics shares in Q4 2025, an estimated $1.45M.
  • Simplify Asset Management first reported a position in Jasper Therapeutics in Q4 2024 and held it in 2 quarters.
  • Simplify Asset Management's Jasper Therapeutics position peaked at $1.45M in Q3 2025.
  • 53 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q4 2025.

Based on Simplify Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.